LORI HAZLEHURST,MARK MCLAUGHLIN,PRIYESH JAIN,WILLIAM S. DALTON
申请号：
US14465106
公开号：
US20150017259A1
申请日:
2014.08.21
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Integrin interaction inhibitors using a beta-turn promoter are described herein. These peptides are useful in treating cancer, such as multiple myeloma, by administering a therapeutically effective amount of the integrin interaction inhibitor. Data show that integrin interaction inhibitors act synergistically or additively interact with anti-proliferative agents such as doxorubicin, SAHA, arsenic trioxide, and etoposide.
